Nurture Genomics, Inc., founded in 2022, provides meaningful health data and insights to parents and healthcare providers.
Subscribe to see Nurture Genomics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Nurture Genomics, Inc. is a genomics company headquartered in United States. Its most recent funding round raised $355,000 in September 2022. Xcout tracks 1 named person at Nurture Genomics, Inc., including Robert Green (Executive Chair).
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $355,000 | — | |
| Series A | $4.3M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Nurture Genomics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Nest Genomics provides a single platform to launch, coordinate, and scale precision medicine from intake to long-term management while maintaining HIPAA compliance.
Genomelink provides personalized DNA analysis reports and ancestry insights by allowing users to upload raw DNA data from other testing services.
Curoverse, Inc. builds open-source software platforms for scientific, clinical, and citizen science genomics communities, and was later acquired by Veritas Genetics.
Headquartered in Taipei, ACT Genomics is a privately held precision medicine company that empowers patients and doctors with cancer profiling and genomic testing services.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.